Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biochimica Et Biophysica Acta. Molecular Cell Research|August 12, 2020
Patients Lung Derived Tumoroids (PLDTs) to model therapeutic responseFrederic Delom, Inaki Begiristain, Thomas Grenier, et al.Biochimica Et Biophysica Acta. Molecular Cell Research|December 5, 2020
Extracellular AGR2 triggers lung tumour cell proliferation through repression of p21<sup>CIP1</sup>Delphine Fessart, Claire de Barbeyrac, Ines Boutin, et al.Oncology Letters|October 16, 2019
Extracellular AGR3 regulates breast cancer cells migration via Src signalingJoanna Obacz, Lucia Sommerova, Daria Sicari, et al.Elife|May 31, 2016
Secretion of protein disulphide isomerase AGR2 confers tumorigenic propertiesDelphine Fessart, Charlotte Domblides, Tony Avril, et al.Journal of Molecular and Cellular Cardiology|November 5, 2013
Proteomic remodeling of proteasome in right heart failureDelphine Fessart, Marie-Laure Martin-Negrier, Stéphane Claverol, et al.Molecular & Cellular Proteomics : MCP|November 13, 2008
Quantitative proteomics characterization of a mouse embryonic stem cell model of Down syndromeYuqin Wang, Claire Mulligan, Gareth Denyer, et al.Frontiers in Immunology|January 22, 2024
Sulconazole inhibits PD-1 expression in immune cells and cancer cells malignant phenotype through NF-κB and calcium activity repressionSimon Pernot, Mercedes Tomé, Isabel Galeano-Otero, et al.American Journal of Human Genetics|September 6, 2008
DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndromeClaudia Canzonetta, Claire Mulligan, Samuel Deutsch, et al.Ebiomedicine|July 14, 2023
Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levelsAoife Murray, Gillian Gough, Ana Cindrić, et al.Pageof 2